✦ LIBER ✦

Phase study: Mavelbine (N) + etoposide (E) + cisplatin (C) in non operable non small cell lung cancer (NSCLC)

✍ Scribed by Richardet, E.; Lazaris, C.; Uribe, A.; Carranza, L.; Cresta, C.; Tolocka, H.; Casarin, O

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Vinorelbine (VB)+ cisplatin (DDP)+ etopo

✍ Marangolo, M.; Intini, C. 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 170 KB

Oral etoposide preceding cisplatin in ad

✍ Focan, C.; Vandermoten, G.; Boossy, J.; Schallier, D. 📂 Article 📅 1988 🏛 Elsevier Science ⚖ 571 KB

Taxol and cisplatin (TP) versus etoposid

✍ T.E. Ciuleanu; C. Cebotaru; I. Radulescu; N. Todor; N. Ghilezan 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 317 KB

Vinorelbine (VNB) + ifosfamide (IFX) in

✍ Rivero, O.; Lozano, M.; Polera, J.; Matiewjuk, M.; Bonicatto, S.; Callejas, C.; 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 161 KB

Concomitant cisplatin, etoposide and rad

✍ Reboul, F.; Vincent, P.; Chauvet, B.; Brewer, Y.; Félix Faure, C.; Taulelle, M. 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 195 KB

Cisplatin, etoposide and mitomycin (CVM)

📂 Article 📅 1991 🏛 Elsevier Science 🌐 English ⚖ 143 KB